Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage 2 and 3
Interventions: DRUG: Fenofibrate|OTHER: Placebo|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: Tanta University